Polio vaccines, SV40 and human tumours, an update on false positive and false negative results

Developments in Biologicals

Volumn 123, Issue , 2006, Pages 109-117

  Elmishad, A G ^a   Bocchetta, M ^a   Pass, H I ^b   Carbone, M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

CONFERENCE PAPER; HUMAN; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MESOTHELIOMA; NEOPLASM; REPRODUCIBILITY; SIMIAN VIRUS 40; STANDARD; VIROLOGY;

FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; MESOTHELIOMA; NEOPLASMS; POLIOVIRUS VACCINES; REPRODUCIBILITY OF RESULTS; SIMIAN VIRUS 40;

EID: 33644632262     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (37)

1. Butel JS, Lednicky JA: Cell and molecular biology of Simian virus 40: Implications for human infections and disease. J Natl Cancer Inst 1999; 91: 119-133.
2. Eddy BE, Borman GS, Grubbs GE, Young RD: Identification of the oncogenic substance in rhesus monkey kidney cell cultures as Simian virus 40. Virology 1962; 17: 65-75.
3. Cicala C, Pompetti F, Carbone M: SV40 induces mesothelioms in hamsters. Am J Pathol 1993; 142: 1524-1533.
4. Kirschtein RL, Gerber P: Ependymomas produced after intracerebral inoculation of SV40 into new-born hamsters. Nature 1962; 195: 299-300.
5. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridhar V, de Bartolomeis A, Esposito V, Giuliano MT, Steinberg SM, Levine AS, Giordano A, Pass HI: Simian virus-40 large-T antigen binds p53 in human mesotheliomas Nat Med 1997a; 8: 908-912.
6. Carbone M, Rizzo P, Pass H: Simian virus 40: the link with human malignant mesothelioma is well established. Anticancer Res 2000; 20 (2A): 875-877.
7. Testa JR, Pass HI, Carbone M: Molecular Biology of Mesothelioma, in De Vita V, Hellman S, Rosenberg S, Williams & Wilkinis (eds): Principles and Practice of Oncology. Philadelphia, PA, Lippincott, 2001, pp 1937-1943.
8. Carbone M, Kratzke RA, Testa JR: The pathogenesis of mesothelioma. Seminars in Oncology 2002; 29 (1): 2-17.
9. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio MA, Mew DJ, Levine AS, Procopio A: Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994; 9: 1781-1790.
10. Gazdar AF, Butel JS, Carbone M: SV40 and human tumours: myth, association or causality? Nat Rev Cancer 2002; 2: 957-964.
11. Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, Pass HI, Rizzo P, Carbone M: Human mesothelial cells are usually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci USA, 2000; 97: 10214-10219.
12. Shivapurkar N, Wiethege T, Wistuba II, Salmon E, Milchgrub S, Muller KM, Churg A, Pass H, Gazdar AF: Presence of simian virus 40 sequences in malignant mesotheliomas and Mesothelial cell proliferatios. J of Cellular Biochemistry 1999; 76: 181-188.
13. Ramael M, Nagels J, Heylen H, De Schepper S, Paulussen J, De Maeyer M, Van Haesendonck C: Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma. Eur Respir J: 1999; 14: 1381-1386.
14. Cristaudo A, Vivaldi A., Sensales G, Guglielmi G, Ciancia E, Elisei R., Ottenga F: Molecular biology studies on mesothelioma tumour samples: preliminary data on H-ras, p21, and SV40. J Environ Pathol. Toxicol Oncol 1995; 14: 29-34.
15. Carbone M, Rizzo P, Procopio A, Guiliano M, Pass HI, Gebhardt MC, Mangham C, Hansen M, Malkin DF, Bushart G, Pompetti P, Picci P, Levine AS, Bergsagel JD, Garcea RL: SV40-like sequences in human bone tumours. Oncogene 1996; 13: 527-535.
16. Yamamoto H, Nakayama T, Murakami H, Hosaka T, Nakamata T, Tsuboyama T, Oka M, Nakamura T, Toguchida J: High incidence of SV40-like sequence detection in tumour and peripheral blood cells of Japanese osteosarcoma patients. Br J Cancer 2000; 82: 1677-1681.
17. Weiss AF, Portmann R, Fischer H, Simon J, Zang KD: Simian virus 40-related antigens in three human meningiomas with defined chromosome loss. Proc Natl Acad Sci U S A 1975; 72 (2): 609-613.
18. Lednicky JA, Garcea RL, Bergsagel DJ, Butel JS: Natural simian virus 40 strains are present in human choroids plexus and ependymoma tumours. Virology 1995; 212: 710-717.
19. Martini F, Iaccheri L, Lazzarin L, Carinci P, Corallini A, Gerosa M, Iuzzolino P, Barbanti-Brodano G, Tognon M: SV40 early region and large T antigen in human brain tumours, peripheral blood cells and sperm fluids from healthy individuals. Cancer Res 1996; 56: 4820-4825.
20. Carbone M, Bocchetta M, Cristaudo A, Emri S, Gazdar A, Jasani B, Lednicky J, Miele L, Mutti L, Pass HJ, Ramel M, Rizzo P, Testa JR: SV40 and human brain tumours. Int J Cancer 2003a; 106: 140-142.
21. David H, Mendoza S, Konishi T, Miller CW: Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett. 2001; 162: 57-64.
22. Shivapukar N, Harada K, Reddy J, Scheuermann RH, Xu Y, McKenna RW, Milchgrub S, Kroft SH, Feng Z, Gazdar AF: Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002; 359: 851-852.
23. Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS, Jorgensen JL, Finch CJ, Butel JS: Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 817-823.
24. Carbone M, Pass HI, Miele L, Bocchetta M: New developments about the association of SV40 with human mesothelioma. Oncogene 2003b; 22: 5173-5180.
25. Heinsohn S, Golta S, Kabisch H, Stadt UZ: Standardized detection of simian virus 40 by real-time quantitative polymerase chain reaction in pediatric malignancies. Hematologica/the hematology journal 2005; 90 (1): 95-100.
26. Salewski H, Bayer TA, Eidhoff U, Preuss U, Weggen S, Scheidtmann KH: Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumour cell lines after loss of large T expression and concomitant mutation in p53. Cancer Research 1999; 59: 1980-1986.
27. Waheed I, Guo ZS, Chen GA, Weiser TS, Nguyen DM, Schrump DS: Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells. Cancer Research 1999; 59 (24): 6068-6073.
28. Foddis R, De Rienzo A, Broccoli D, Bocchetta M, Stekala E, Rizzo P, Tosolini A, Jhanwar SC, Pass HI, Testa JR, Carbone M: SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002; 21: 1434-1442.
29. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, Weinberg RA: Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002; 22 (7): 2111-2123.
30. Erratum, in Mol Cell Biol 2002; 22 (10): 3562.
31. Jensen F, Koprowski H, Pagano JS, Ponten J, Ravdin RG: J Natl Cancer Inst 1964; 32: 917-937.
32. Sweet BH, Hilleman MR: The vaculating virus SV40. Proc Soc Exp Biol Med 1960; 105: 420-427.
33. Shah KV, Nathanson N: Human exposure to SV40. Review and comment. Am J Epidomiol 1976; 103: 1-12.
34. Dang-Tan T, Mahmud S, Puntoni R, Franco E: Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association. Oncogene 2004; 23: 6535-6540.
35. IOM Report: Immunization safety review. SV40 contamination of poliovaccine and cancer, in Stratton K, Almario DA, McCormick M (eds): The National Academy of Sciences. Washington, DC, The National Academies Press, 2003, www.nep.edu.
36. Klein G, Powers A, Croce CM: Association of SV40 with human tumours. Oncogene 2002; 21: 1141-1149.
37. Wong M, Pagano JS, Schiller JT, Tevethia SS, Raab-Traub N, Gruber J: New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer. J Natl Cancer Inst 2002; 94 (24): 1832-1836.